431 related articles for article (PubMed ID: 28082802)
1. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
Buanes TA
World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
[TBL] [Abstract][Full Text] [Related]
2. Role of surgery in pancreatic cancer.
Buanes TA
World J Gastroenterol; 2017 Jun; 23(21):3765-3770. PubMed ID: 28638216
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
4. Current standards and new innovative approaches for treatment of pancreatic cancer.
Conroy T; Bachet JB; Ayav A; Huguet F; Lambert A; Caramella C; Maréchal R; Van Laethem JL; Ducreux M
Eur J Cancer; 2016 Apr; 57():10-22. PubMed ID: 26851397
[TBL] [Abstract][Full Text] [Related]
5. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
6. Update on the management of pancreatic cancer: surgery is not enough.
Ansari D; Gustafsson A; Andersson R
World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
[TBL] [Abstract][Full Text] [Related]
7. Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
Elebro J; Ben Dror L; Heby M; Nodin B; Jirström K; Eberhard J
Acta Oncol; 2016; 55(3):286-96. PubMed ID: 26362587
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the ampulla of Vater: what treatment options are available?
Senatore FJ; Ynson ML; Dasanu CA
J Oncol Pharm Pract; 2015 Oct; 21(5):364-9. PubMed ID: 24906539
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater.
Hoffman JP; Cooper HS; Young NA; Pendurthi TK
J Hepatobiliary Pancreat Surg; 1998; 5(3):251-4. PubMed ID: 9880771
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer-improved care achievable.
Buanes TA
World J Gastroenterol; 2014 Aug; 20(30):10405-18. PubMed ID: 25132756
[TBL] [Abstract][Full Text] [Related]
12. Histological and Molecular Subclassification of Pancreatic and Nonpancreatic Periampullary Cancers: Implications for (Neo) Adjuvant Systemic Treatment.
Erdmann JI; Eskens FA; Vollmer CM; Kok NF; Groot Koerkamp B; Biermann K; van Eijck CH
Ann Surg Oncol; 2015 Jul; 22(7):2401-7. PubMed ID: 25503345
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients.
Baghmar S; Agrawal N; Kumar G; Bihari C; Patidar Y; Kumar S; Chattopadhyay TK; Panda D; Arora A; Pamecha V
J Gastrointest Cancer; 2019 Sep; 50(3):361-369. PubMed ID: 29464529
[TBL] [Abstract][Full Text] [Related]
14. Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue.
Booy S; Hofland LJ; Waaijers AM; Croze E; van Koetsveld PM; de Vogel L; Biermann K; van Eijck CH
Pancreas; 2015 Jan; 44(1):99-105. PubMed ID: 25072284
[TBL] [Abstract][Full Text] [Related]
15. Management of a patient with borderline resectable pancreatic cancer. Case report and review.
Shah AP; Strauss JB; Leslie WT; Shah A; Mahon B; Abrams RA
Oncology (Williston Park); 2008 Nov; 22(13):1524-9. PubMed ID: 19133606
[TBL] [Abstract][Full Text] [Related]
16. Advances in Molecular Pathology and Treatment of Periampullary Cancers.
Chandrasegaram MD; Chen JW; Price TJ; Zalcberg J; Sjoquist K; Merrett ND
Pancreas; 2016 Jan; 45(1):32-9. PubMed ID: 26348463
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy.
Erdmann JI; Morak MJ; Duivenvoorden HJ; van Dekken H; Kazemier G; Kok NF; van Eijck CH
HPB (Oxford); 2015 Jul; 17(7):573-9. PubMed ID: 25800041
[TBL] [Abstract][Full Text] [Related]
18. Treatment Approach to Adenocarcinoma of the Ampulla of Vater.
Patel M; Uboha NV
Curr Treat Options Oncol; 2021 Sep; 22(11):103. PubMed ID: 34586537
[TBL] [Abstract][Full Text] [Related]
19. Ampullary and periampullary adenocarcinoma: new challenges in management of recurrence.
Ramfidis VS; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):158-60. PubMed ID: 23474562
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.
Smeenk HG; van Eijck CH; Hop WC; Erdmann J; Tran KC; Debois M; van Cutsem E; van Dekken H; Klinkenbijl JH; Jeekel J
Ann Surg; 2007 Nov; 246(5):734-40. PubMed ID: 17968163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]